magrolimab,azacitidine
gilead sciences
['leukemia', 'aza ', '+aza', 'leusm', 'improve ', 'magrolimab']
congress #asco22 | compares the posters by lachowiez, de botton &amp; . he considers if oral therapy only would be possible in the future with ivo+ven alone &amp; if adding a third agent to magrolimab+aza would improve outcomes #leusm #leukemia 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm